Blood pressure telemonitoring and remote counseling of hypertensive patients: pros and cons
https://doi.org/10.15829/1560-4071-2020-4066
Abstract
Home blood pressure monitoring (HBPM) is strongly recommended by current guidelines as an effective out-of-office diagnostic and monitoring tool in patients with hypertension (HTN). However, there are personal, cultural, logistic difficulties owing to low effectiveness of HBPM. These put HBPM at a disadvantage in routine clinical practice. As such, telehealth solutions are of special interest nowadays, particularly blood pressure telemonitoring (BPTM) with or without remote counseling. BPTM might become something of digital assistant in the long-term patients’ follow-up and it fits well into the practice of continuity of medical care. The purpose of this review is to highlight not only the benefits of BPTM, but important discrepancies that may impede its widespread implementation in everyday clinical work. Critical comments address the lack of long-term, high-quality studies, absence of hard clinical outcomes and uncertainty on the best technical performance.
Keywords
hypertension,
e-health,
telemedicine,
blood pressure telemonitoring,
m-health,
blood pressure self-monitoring
Supporting agencies: The study was supported by a Russian Science Foundation grant № 17-15-01177.
About the Authors
M. V. Ionov
Almazov National Medical Research Center;
ITMO University
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
N. E. Zvartau
Almazov National Medical Research Center;
ITMO University
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
A. O. Konradi
Almazov National Medical Research Center;
ITMO University
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
E. V. Shlyakhto
Almazov National Medical Research Center
Russian Federation
St. Petersburg
Russian Federation
St. Petersburg
References
1. Padmanabhan S, Aman A, Dominiczak AF. Recent Findings in the Genetics of Blood Pressure: How to Apply in Practice or Is a Moonshot Required? Curr Hypertens Rep 2018;20. doi:10.1007/s11906-018-0863-1.
2. Dzau VJ, Balatbat CA. Future of Hypertension. Hypertension 2019;74:450–7. doi:10.1161/HYPERTENSIONAHA.119.13437.
3. Beaney T, Schutte AE, Stergiou GS, et al. May Measurement Month 2019. Hypertension 2020;76:333–41. doi:10.1161/HYPERTENSIONAHA.120.14874.
4. Poulter NR, Borghi C, Parati G, et al. Medication adherence in hypertension. Journal of Hypertension 2020;38:579–587. doi:10.1097/HJH.0000000000002294.
5. Shimbo D, Artinian NT, Basile JN, et al. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation 2020;142:e42-e63. doi:10.1161/CIR.0000000000000803.
6. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011;342:d3621. doi:10.1136/bmj.d3621.
7. Fuchs SC, de Mello RGB, Fuchs FC. Home Blood Pressure Monitoring Is Better Predictor of Cardiovascular Disease and Target Organ Damage than Office Blood Pressure: A Systematic Review and Meta-Analysis. Curr Cardiol Rep 2013;15:413. doi:10.1007/s11886-013-0413-z.
8. Hoshide S, Yano Y, Haimoto H, et al. Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study. Hypertension 2016;68:54–61. doi:10.1161/HYPERTENSIONAHA.116.07201.
9. McGowan N, Padfield PL. Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure? J Hum Hypertens 2010;24:801–6. doi:10.1038/jhh.2010.15.
10. Carrera PM, Lambooij MS. Implementation of Out-of-Office Blood Pressure Monitoring in the Netherlands: From Clinical Guidelines to Patients’ Adoption of Innovation. Medicine (Baltimore) 2015;94:e1813. doi:10.1097/MD.0000000000001813.
11. Ringrose JS, Bapuji R, Coutinho W, et al. Patient perceptions of ambulatory blood pressure monitoring testing, tolerability, accessibility, and expense. J Clin Hypertens (Greenwich) 2020;22:16–20. doi:10.1111/jch.13760.
12. Mengden T, Hernandez Medina RM, Beltran B, et al. Reliability of reporting self-measured blood pressure values by hypertensive patients. Am J Hypertens 1998;11:1413–7. doi:10.1016/s0895-7061(98)00241-6.
13. Omboni S, Panzeri E, Campolo L. E-Health in Hypertension Management: an Insight into the Current and Future Role of Blood Pressure Telemonitoring. Curr Hypertens Rep 2020;22:42. doi:10.1007/s11906-020-01056-y.
14. Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med 2017;14:e1002389. doi:10.1371/journal.pmed.1002389.
15. Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J 2020; 14;55:2000547. doi:10.1183/13993003.00547-2020.
16. Bashshur R, Doarn CR, Frenk JM, et al. Telemedicine and the COVID-19 Pandemic, Lessons for the Future. Telemed J E Health 2020. doi:10.1089/tmj.2020.29040.rb.
17. Ionov MV, Zvartau NE, Emelyanov IV, et al. Telemonitoring and remote counseling in hypertensive patients. Looking for new ways to do old jobs. Arterial’naya Gipertenziya (Arterial Hypertension) 2019;25(4):337–356. (In Russ.). doi:10.18705/1607419X-2019-25-4-337-356.
18. Ionov MV, Zvartau NE, Konradi AO. Telemedicine and out-of-office blood pressure monitoring: up-to-date view of ESC/ESH. Arterial’naya Gipertenziya (Arterial Hypertension). 2018;24(6):631-636. (In Russ.). doi:10.18705/1607-419X-2018-24-6-631-636.
19. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021–104. doi:10.1093/eurheartj/ehy339.
20. Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013;31:455–67; discussion 467-468. doi:10.1097/HJH.0b013e32835ca8dd.
21. Duan Y, Xie Z, Dong F, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens 2017;31:427–37. doi:10.1038/jhh.2016.99.
22. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 2010;376:163–72. doi:10.1016/S0140-6736(10)60964-6.
23. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet 2018;391:949–59. doi:10.1016/S0140-6736(18)30309-X.
24. Kitsiou S, Paré G, Jaana M. Systematic reviews and meta-analyses of home telemonitoring interventions for patients with chronic diseases: a critical assessment of their methodological quality. J Med Internet Res 2013;15:e150. doi:10.2196/jmir.2770.
25. Bae J-M. Value-based medicine: concepts and application. Epidemiol Health 2015;37:e2015014. doi:10.4178/epih/e2015014.
26. Lee CJ, Park WJ, Suh J-W, et al. Relationship between health-related quality of life and blood pressure control in patients with uncontrolled hypertension. J Clin Hypertens (Greenwich) 2020. doi:10.1111/jch.13941.
27. Madsen LB, Kirkegaard P, Pedersen EB. Health‐related quality of life (SF‐36) during telemonitoring of home blood pressure in hypertensive patients: A randomized, controlled study. Blood Pressure 2008;17:227–32. doi:1080/08037050802433701.
28. Kao C-W, Chen T-Y, Cheng S-M, et al. A Web-Based Self-Titration Program to Control Blood Pressure in Patients With Primary Hypertension: Randomized Controlled Trial. Journal of Medical Internet Research 2019;21:e15836. doi:10.2196/15836.
29. Ionov MV, Yudina YS, Avdonina NG, et al. Patient‑oriented assessment of blood pressure telemonitoring and remote counseling in hypertensive patients: a pilot project. Arterial’naya Gipertenziya (Arterial Hypertension). 2018;24:15-28. (In Russ.). doi:10.18705/1607-419X-2018-24-1-15-28.
30. Oj W, H N, Nj S. QALYs in Cost-Effectiveness Analysis: An Overview for Cardiologists. Heart (British Cardiac Society) 2015;101. doi:10.1136/heartjnl-2015-308255.
31. Zhi L, Qiaojun L, Yanbo Z. Development and validation of patient-reported outcomes scale for hypertension. Int J Qual Health Care 2015;27:369–76. doi:10.1093/intqhc/mzv060.
32. Weldring T, Smith SMS. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insights 2013;6:61–8. doi:10.4137/HSI.S11093.
33. Ionov MV, Zvartau NE, Dubinina EA, et al. Hypertension specific patient-reported outcome measure. Part III: validation, responsiveness and reliability assessment. Russian Journal of Cardiology. 2020;25(3):3438. (In Russ.). doi:10.15829/1560-40712019-3438.
34. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996;9:285–92. doi:10.1016/0895-7061(95)00353-3.
35. Parati G, Omboni S, Albini F, et al. Home blood pressure telemonitoring improves hypertension control in general practice. The TeleBPCare study. J Hypertens 2009;27:198–203. doi:10.1097/hjh.0b013e3283163caf.
36. Morawski K, Ghazinouri R, Krumme A, et al. Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial. JAMA Intern Med 2018;178:802–9. doi:10.1001/jamainternmed.2018.0447.
37. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep 2015;17:535. doi:10.1007/s11906-015-0535-3.
38. Palmer MJ, Barnard S, Perel P, et al. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev 2018;6:CD012675. doi:10.1002/14651858.CD012675.pub2.
39. Posnenkova OM, Korotin AS, Ionova TS, et al. Healthcare system for patients with acute coronary syndrome in Saratov region. Cardio-IT 2015;2:e0304 (In Russ.). doi:10.15275/cardioit.2015.0203.
40. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013;310:46–56. doi:10.1001/jama.2013.6549.
41. Crowley MJ, Smith VA, Olsen MK, et al. Treatment intensification in a hypertension telemanagement trial: clinical inertia or good clinical judgment? Hypertension 2011;58:552–8. doi:10.1161/HYPERTENSIONAHA.111.174367.
42. Bobrie G, Postel-Vinay N, Delonca J, et al. Self-measurement and self-titration in hypertension: a pilot telemedicine study. Am J Hypertens 2007;20:1314–20. doi:10.1016/j.amjhyper.2007.08.011.
43. Parati G, Dolan E, McManus RJ, et al. Home blood pressure telemonitoring in the 21st century. J Clin Hypertens (Greenwich) 2018;20:1128–32. doi:10.1111/jch.13305.
44. Hebert PL, Sisk JE, Tuzzio L, et al. Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial. J Gen Intern Med 2012;27:630–9. doi:10.1007/s11606-011-1924-1.
45. Bosworth HB, Olsen MK, Grubber JM, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med 2009;151:687–95. doi:10.7326/0003-4819-151-10-200911170-00148.
46. Kiselev AR, Gridnev VI, Shvartz VA, et al. Active ambulatory care management supported by short message services and mobile phone technology in patients with arterial hypertension. J Am Soc Hypertens 2012;6:346–55. doi:10.1016/j.jash.2012.08.001.
47. Widmer RJ, Collins NM, Collins CS, et al. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc 2015;90:469–80. doi:10.1016/j.mayocp.2014.12.026.
48. Yagudina R.I., Sorokovikov I.V. Methodology of cost-utility analysis in pharmacoeconomic studies. Farmakoekonomika. Modern Pharmacoeconomic and Pharmacoepidemiology. 2012;5:9-12 (In Russ.)
49. Musina NZ, Fedyaeva VK. The use of QALY as an integral measure of effectiveness in the evaluation of medical technologies. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya/Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2017;10:66-71 (In Russ.). doi:10.17749/2070-4909.2017.10.1.066-071.
50. Kaambwa B, Bryan S, Jowett S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol 2014;21:1517–30. doi:1177/2047487313501886.
51. Monahan M, Jowett S, Nickless A, et al. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4). Hypertension 2019;73:1231–9. doi:10.1161/HYPERTENSIONAHA.118.12415.
52. Reed SD, Li Y, Oddone EZ, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens 2010;23:142–8. doi:10.1038/ajh.2009.215.
53. Maksimchuk-Kolobova NS, Tarlovskaya EI, Malchikova SV. Economic evaluation of combined therapy of arterial hypertension by Markov’s modeling. Ration Pharmacother Cardiol. 2013;9:251-257. (In Russ.)
54. Kontsevaya AV, Suvorova EI, Khudyakov MB. Economic efficiency of renal denervation in patients with resistant hypertension: results of markov modeling. Kardiologiia 2014;1:41—48. (In Russ.)
55. Ionov MV, Zhukova OV, Zvartau NE, et al. Assessment of the clinical efficacy of telemonitoring and distant counseling in patients with uncontrolled hypertension. Therapeutic Archive. 2020; 92 (1): 49–55. (In Russ.). doi:10.26442/00403660.2020.0 1.000481.
56. Oleynikov VE, Chizhova OV, Dzhazovskaya IN, et al. Economic justification of the application of the automatic remote blood pressure monitoring. Health Care of the Russian Federation. 2019; 63:14-21. (In Russ.). doi:10.18821/0044-197X-2019-63-1-14-21.
57. Parati G, Ochoa JE, Postel-Vinay N, et al. Home Blood Pressure Telemonitoring: Conventional Approach and Perspectives from Mobile Health Technology, 2020. doi:10.1007/978-3-030-23065-4_11.
58. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther 2015;13:209–21. doi:10.1586/14779072.2015.1001368.
59. Plante TB, Urrea B, MacFarlane ZT, et al. Validation of the Instant Blood Pressure Smartphone App. JAMA Intern Med 2016;176:700–2. doi:10.1001/jamainternmed.2016.0157.
60. Will Cuffless Blood Pressure Make the Sphygmomanometer Obsolete? http://www.medscape.com/viewarticle/931926 (July 27, 2020).
61. Kumar N, Khunger M, Gupta A, et al. content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens 2015;9:130–6. doi:10.1016/j.jash.2014.12.001.
62. Dorsey ER, Topol EJ. State of Telehealth. New England Journal of Medicine 2016;375:154–61. doi:10.1056/NEJMra1601705.
63. Palacholla RS, Fischer N, Coleman A, et al. Provider- and Patient-Related Barriers to and Facilitators of Digital Health Technology Adoption for Hypertension Management: Scoping Review. JMIR Cardio 2019;3:e11951. doi:10.2196/11951.
Review
For citations:
Ionov M.V., Zvartau N.E., Konradi A.O., Shlyakhto E.V. Blood pressure telemonitoring and remote counseling of hypertensive patients: pros and cons. Russian Journal of Cardiology. 2020;25(10):4066. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4066
Views:
1228
Email this article 